Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:assetsUnderManagement |
Over $1 billion
|
| gptkbp:focusesOn |
gptkb:biotechnology
Life sciences |
| gptkbp:foundedIn |
2002
|
| gptkbp:founder |
gptkb:John_Diekman
gptkb:Andrew_Schwab Carin Mueller Scott Rocklage |
| gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts
gptkb:San_Francisco,_California |
| gptkbp:investedIn |
Early-stage companies
|
| gptkbp:notableInvestment |
gptkb:Casma_Therapeutics
gptkb:Arvinas gptkb:Pulmatrix gptkb:Aprea_Therapeutics Ensoma Homology Medicines Pear Therapeutics |
| gptkbp:website |
https://www.5amventures.com/
|
| gptkbp:bfsParent |
gptkb:Nomad_Health
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
5AM Ventures
|